Fourth Quarter Fiscal Year 2025 Earnings Call July 16, 2025 © 2025 AAR CORP. All rights reserved worldwide. 1 Forward-looking Statements Note: All results and expectations in the presentation reflect continuing operations unless otherwise noted. This presentation contains certain statements relating to future results, which are forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, which reflect management's expectations about future conditions, including ...

Company Overview - Prologis owned or had investments in properties and development projects expected to total approximately 13 billion square feet in 20 countries as of June 30, 2025[9] - The company leases modern logistics facilities to approximately 6,500 customers[9] - The build out of land (TEI) is $415 billion[10] Financial Performance - Rental and other revenues for the three months ended June 30, 2025, were $2037 million, compared to $1853 million for the same period in 2024[25] - Core FFO attributable to common stockholders/unitholders for the three months ended June 30, 2025, was $1396 million, compared to $1281 million for the same period in 2024[25] - AFFO attributable to common stockholders/unitholders for the three months ended June 30, 2025, was $1036 million, compared to $1072 million for the same period in 2024[25] - Strategic capital revenues for the three months ended June 30, 2025, were $147 million, compared to $155 million for the same period in 2024[25] Operations - The company's annual NOI is $64 billion[12] - 85% of the company's NOI comes from the U S[10] - The average occupancy for the Prologis Share was 95%[66] Strategic Capital - The company's gross AUM is $205 billion[17] - The company's Prologis Share AUM is $139 billion[23] - Fees and promotes are $452 million[14] Capital Deployment - Value creation from stabilizations is $731 million[23] - The estimated build out of the land portfolio is 216 million square feet, with a TEI of $379 billion[99]

Financial Performance Highlights - GAAP diluted EPS increased by 28% quarter-over-quarter (QoQ) and 14% year-over-year (YoY)[32] - Return on Assets rose by 23 basis points (bps) QoQ[32] - Return on Common Equity increased by 203 bps QoQ[32] - Provision for Credit Losses declined by 4% QoQ and 17% YoY[32] - Diluted Net Operating EPS increased +27% QoQ and +13% YoY[33] Balance Sheet - Average loans increased by $563 million QoQ[43] - CRE loans declined by 4% (-$926 million), reflecting higher payoffs and the sale of an out-of-footprint portfolio[43] - Consumer loans rose by 4% (+$1 billion), reflecting higher average recreational finance and automobile loans[43] - Average deposits increased by $22 billion or 1% QoQ[47] - Repurchased $11 billion of common shares in 2Q25[39] Income Statement - Noninterest income increased by $72 million or 12% QoQ[52] - Noninterest expense decreased by $79 million, or -6% QoQ[57] - Taxable-equivalent net interest income increased +$15 million or 1% QoQ[38] Credit Quality - Criticized loans decreased -$10 billion QoQ[68]

SECOND QUARTER 2025 RESULTS NASDAQ: FULT Data as of or for the period ended June 30, 2025 unless otherwise noted This presentation may contain forward-looking statements with respect to Fulton Financial Corporation's (the "Corporation" or "Fulton") financial condition, results of operations and business. Do not unduly rely on forward-looking statements. Forward-looking statements can be identified by the use of words such as "may," "should," "will," "could," "estimates," "predicts," "potential," "continue," ...

Financial Performance - Net income reached $1.643 billion, with diluted earnings per share at $3.85, reflecting a 10% linked quarter growth and 11% year-over-year growth[32] - Pretax, pre-provision earnings (PPNR) grew by 10% linked quarter and 11% year-over-year[8, 32] - Total revenue increased by 4% linked quarter and 5% year-over-year, reaching $5.661 billion[8, 32] - The company announced a dividend increase of $0.10, or 6%, to $1.70 per common share[8] - Return on average tangible common equity (ROTCE) was 15.6%[8] Balance Sheet - Average loans increased by 2% linked quarter, totaling $322.8 billion, marking the strongest loan growth since 4Q22[8, 13] - Total deposits increased by 1% linked quarter, reaching $423 billion[13] - Common shareholders' equity increased by 3% linked quarter and 13% year-over-year, reaching $50.7 billion[13] Business Segments - Net consumer checking accounts grew by 2% year-over-year, including 6% growth in the Southwest[12] - Brokerage assets increased by 7% year-over-year to a record level of $87 billion[12] - Asset Management fees increased 5% year-over-year to a record first-half level[12] Credit Quality - Nonperforming loans (NPLs) decreased, with the NPL ratio to total loans at 0.65%[39, 41] - Net loan charge-offs (NCOs) also declined, with the NCO ratio to average loans at 0.25%[39, 41] Guidance - The company anticipates average loans to increase by approximately 1% for the full year 2025[44] - Net interest income is expected to increase by approximately 7% for the full year 2025[44] - Fee income is projected to increase by 4% to 5% for the full year 2025[44]

Investor Call SECOND QUARTER 2025 JULY 16, 2025 Time: 8:30 AM CT Webcast: www.pnfp.com (investor relations) M. TERRY TURNER, PRESIDENT AND CEO HAROLD R. CARPENTER, EVP AND CFO Safe Harbor Statements Forward Looking Statements All statements, other than statements of historical fact, included in this presentation, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act o ...

Financial Performance - The company's net revenues for 2Q25 reached $14.58 billion[3], while year-to-date (YTD) net revenues amounted to $29.65 billion[3] - Net earnings for 2Q25 were $3.72 billion[3], and YTD net earnings totaled $8.46 billion[3] - Diluted earnings per share (EPS) for 2Q25 stood at $10.91[3], with a YTD EPS of $25.07[3] - The annualized return on equity (ROE) for 2Q25 was 12.8%[3], and the YTD ROE was 14.8%[3] - The annualized return on tangible equity (ROTE) for 2Q25 was 13.6%[3], with a YTD ROTE of 15.8%[3] Segment Performance - Global Banking & Markets reported net revenues of $10.12 billion for 2Q25, a 24% increase compared to 2Q24[6] - Asset & Wealth Management's net revenues for 2Q25 were $3.778 billion, a 3% decrease compared to 2Q24[6] - Platform Solutions generated net revenues of $685 million for 2Q25, a 2% increase compared to 2Q24[6] Asset & Wealth Management - Assets Under Supervision (AUS) - Total assets under supervision (AUS) reached a record $3.29 trillion[3] - Long-term AUS net inflows were $17 billion[28] - Liquidity products experienced net outflows of $12 billion[28]

Second Quarter 2025 Earnings July 16, 2025 Disclaimers Non-GAAP Information Certain measures included in this document are "non-GAAP," meaning they are not presented in accordance with generally accepted accounting principles in the U.S. and also are not codified in U.S. banking regulations currently applicable to FHN. Although other entities may use calculation methods that differ from those used by FHN for non-GAAP measures, FHN's management believes such measures are relevant to understanding the financi ...

Business Update July 16, 2025 2 Disclaimer Certain information in this presentation and discussed on the conference call which this presentation accompanies constitutes forward -looking information within the meaning of the Private Securities Litigation Reform Act of 1995 . Statements in this presentation regarding the Company's business that are not historical facts are "forward -looking statements" that involve risks and uncertainties and are based on current expectations and management estimates ; actual ...

Q2 2025 Financial Performance - Worldwide sales reached $23.7 billion, a 5.8% increase compared to Q2 2024, with operational sales growth of 4.6%[47] - U S sales increased by 7.8% to $13.5 billion in Q2 2025 from $12.6 billion in Q2 2024[47] - Adjusted earnings were $6.7 billion, and adjusted EPS was $2.77[49] - GAAP net earnings increased to $5.5 billion, a rise of 18.2%[49] Innovative Medicine - Innovative Medicine sales reached $15.202 billion, with operational growth of 3.8%[51] - Oncology sales grew by 22.3% operationally, reaching $6.312 billion[51] - Immunology sales declined by 16% operationally, totaling $3.993 billion, impacted by STELARA biosimilar competition[51] MedTech - MedTech sales were $8.541 billion, with operational growth of 6.1%[53] - Cardiovascular sales increased by 22.3% operationally, reaching $2.313 billion[53] - Orthopaedics sales decreased by 1.6% operationally, totaling $2.305 billion[53] Guidance - The company increased its operational sales guidance for 2025 to 4.8% and adjusted operational EPS guidance to 7.0% (midpoints)[62] - Operational sales are projected to be between $92.7 billion and $93.1 billion[62]